Tansna Therapeutics
St Louis
About Tansna Therapeutics
Tansna Therapeutics is a developer of an oral anticonvulsant agent that reduces seizure frequency in patients with epilepsy. The company was founded in 2010.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $850.0K
- Funding stage: Seed
- Last round: Seed (Feb 2014)
- Website: tansna.com
- Phone: +1 314 932 4038
Industries & Categories
Biotechnology, Health Care, Innovation Management, Therapeutics
Canonical: https://fsome.com/organization/tansna-therapeutics-2108134 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.